Lonza Publishes Invitation to the 2022 Annual General Meeting and 2021 Annual and Sustainability Reports
. Annual General Meeting to take place on 5 May 2022 at the company’s headquarters in Basel, Switzerland Albert M. Bae…
. Annual General Meeting to take place on 5 May 2022 at the company’s headquarters in Basel, Switzerland Albert M. Bae…
Lonza erzielt einen Umsatz von CHF 5.4 Milliarden und einem Umsatzwachstum von 20% (kWk)1 CHF 1.7 Milliarden Kern-EBIT…
Lonza delivers CHF 5.4 billion sales and 20% CER1 sales growth CHF 1.7 billion CORE EBITDA resulted in a margin of 30.8…
Biogen Idec (NASDAQ: BIIB) and Neurimmune Holding AG today announced that Biogen Idec has acquired a subsidiary of Neuri…
The ZKB TECHNOPARK® Pioneer Award, which has been sponsored by the Zürcher Kantonalbank since 2000, was presented for th…
Neurimmune Therapeutics AG today announced that, following the successful completion of key research milestones, its lea…
CT Atlantic AG, ein neu gegründetes Biotechnologieunternehmen mit Schwerpunkt auf eine zukünftige Krebstherapie durch v…